Search
EMEND 125 MG / 80 MG, Gélule
Details
| --- | Description |
|---|---|
| Pack | Boite contenant une capsule de 125 MG et 2 capsules de 80 MG. |
| Strength (Dosage) | 125 MG | 80 MG |
| Laboratory | MSD MAROC |
| Ingredients | Aprépitant |
| Therapeutic class | Antiémétique, antagoniste des récepteurs de la neurokinine 1 (NK1) |
| ATC code | A04AD12 |
| PPH | $56.50 |
| PPV | $87.20 |
| Refundable | No |
| Refund base | $0.00 |
| Refund rate | $0.00 |
| Table | A |
| Marketing status | Commercialized |
| Type | Not specified |
| Uses | Emend associé à un antagoniste 5-HT3 et à la dexaméthasone est indiqué chez les adultes pour la prévention des nausées et des vomissements aigus et retardés induits par une chimiothérapie hautement émétisante, y compris le cisplatine à des doses élevées, et par une chimiothérapie modérément émétisante. |
| Warnings | |
| Dosage | |
| Avoid | |
| Side effects | |
| Interactions |
Medications from the same laboratory
Disclaimer
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
The materials provided by this website, https://www.doctolist.com, are for informational purposes only and are not provided as legal advice or medical advice. No reader should act on the basis of this material without seeking appropriate professional advice with respect to the particular facts and applicable law. The materials are not presented as correct, complete or up-to-date, and are not a substitute for a visit or consultation with a physician or health professional.
Report a problem